Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 7/20 | 0.50 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | GCGR | P47871 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18146372 | 0.86 | CSF1R (0.47) | CSF1RP4HTMKDRPPARG | |
| SCHEMBL18160402 | 0.85 | KCNQ3 (0.60) | CSF1RLMNAALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL18146141 | 0.82 | SMN1; SMN2 (0.62) | LMNAMEN1KMT2ASMN1; SMN2PPARG | |
| SCHEMBL18160286 | 0.80 | PPARG (0.53) | CSF1RLMNAALDH1A1KDM4EMEN1 | |
| SCHEMBL12900908 | 0.79 | SMN1; SMN2 (0.55) | LMNAALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL18160382 | 0.78 | F10 (0.62) | LMNAALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18160306 | 0.78 | HDAC8 (0.68) | LMNAALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22227949 | 0.77 | P4HTM (0.55) | P4HTMKDRLMNAALDH1A1KDM4E | |
| SCHEMBL18160285 | 0.76 | CSF1R (0.74) | CSF1RALDH1A1 | |
| SCHEMBL18160302 | 0.75 | TYK2 (0.73) | CSF1RMEN1KMT2ASMN1; SMN2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9781935-B2 | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto | DOW AGROSCIENCES LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160304522-A1 | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto | DOW AGROSCIENCES LLC (US) | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304522-A1 | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto | ACHE, DDT, MLYCD | CSF1R 4210/4885P4HTM 2825/4885KDR 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.